Septerna (NASDAQ:SEPN) COO Sells $149,640.00 in Stock

Septerna, Inc. (NASDAQ:SEPN) COO Elizabeth Bhatt sold 4,000 shares of the company’s stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $37.41, for a total value of $149,640.00. Following the completion of the sale, the chief operating officer owned 174,209 shares of the company’s stock, valued at $6,517,158.69. This trade represents a 2.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Elizabeth Bhatt also recently made the following trade(s):

• On Tuesday, August 11th, Elizabeth Bhatt sold 25,000 shares of Septerna stock. The stock was sold at an average price of $44.00, for a total transaction of $1,100,000.00.

Septerna Trading Up 0.1%

SEPN traded up $0.03 on Monday, hitting $36.38. 410,189 shares of the company’s stock traded hands, compared to its average volume of 416,043. The company’s 50 day simple moving average is $39.25 and its 200-day simple moving average is $33.66. Septerna, Inc. has a one year low of $17.55 and a one year high of $51.10. The firm has a market cap of $1.70 billion, a price-to-earnings ratio of -67.37 and a beta of 2.29.

Septerna (NASDAQ:SEPN) last posted its earnings results on Monday, August 10th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.43) by $0.14. Septerna had a negative net margin of 24.51% and a negative return on equity of 9.57%. The company had revenue of $26.75 million during the quarter, compared to analysts’ expectations of $19.22 million. As a group, equities analysts anticipate that Septerna, Inc. will post -1.41 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in SEPN. Engineers Gate Manager LP lifted its stake in Septerna by 5.0% in the 2nd quarter. Engineers Gate Manager LP now owns 17,350 shares of the company’s stock valued at $581,000 after buying an additional 822 shares in the last quarter. Strs Ohio increased its position in shares of Septerna by 17.8% during the first quarter. Strs Ohio now owns 17,200 shares of the company’s stock valued at $413,000 after acquiring an additional 2,600 shares during the last quarter. Squarepoint Ops LLC raised its holdings in shares of Septerna by 17.3% in the 2nd quarter. Squarepoint Ops LLC now owns 21,219 shares of the company’s stock valued at $711,000 after buying an additional 3,136 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in Septerna during the 4th quarter worth approximately $88,000. Finally, Bank of New York Mellon Corp increased its holdings in Septerna by 6.1% during the 1st quarter. Bank of New York Mellon Corp now owns 58,709 shares of the company’s stock worth $1,411,000 after purchasing an additional 3,377 shares during the period.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Truist Financial boosted their price objective on shares of Septerna from $35.00 to $43.00 and gave the company a “buy” rating in a research report on Wednesday, July 1st. Stifel Nicolaus set a $49.00 target price on Septerna in a research report on Tuesday, August 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Septerna in a report on Thursday. JPMorgan Chase & Co. raised their target price on shares of Septerna from $38.00 to $48.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. Finally, JonesTrading increased their price objective on shares of Septerna from $43.00 to $62.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $52.44.

Septerna Company Profile

Septerna, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing oral medicines that target G protein-coupled receptors (GPCRs). GPCRs are a large class of cell-surface proteins involved in numerous biological processes and are established targets for therapies across a range of diseases.

The company uses its proprietary Native Complex Platform to study GPCRs in their native state and identify small-molecule medicines for targets that have historically been difficult to address.